- Home
- ISTR vs CRVS Comparison
ISTR vs CRVS Comparison
Compare ISTR & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISTR
- CRVS
- Stock Information
- Founded
- ISTR 2006
- CRVS 2014
- Country
- ISTR United States
- CRVS United States
- Employees
- ISTR N/A
- CRVS N/A
- Industry
- ISTR Major Banks
- CRVS Biotechnology: Pharmaceutical Preparations
- Sector
- ISTR Finance
- CRVS Health Care
- Exchange
- ISTR Nasdaq
- CRVS Nasdaq
- Market Cap
- ISTR 189.6M
- CRVS 305.4M
- IPO Year
- ISTR 2014
- CRVS 2016
- Fundamental
- Price
- ISTR $21.87
- CRVS $4.11
- Analyst Decision
- ISTR Buy
- CRVS Strong Buy
- Analyst Count
- ISTR 1
- CRVS 4
- Target Price
- ISTR $27.00
- CRVS $15.00
- AVG Volume (30 Days)
- ISTR 46.0K
- CRVS 1.2M
- Earning Date
- ISTR 07-21-2025
- CRVS 08-05-2025
- Dividend Yield
- ISTR 1.89%
- CRVS N/A
- EPS Growth
- ISTR 22.25
- CRVS N/A
- EPS
- ISTR 2.19
- CRVS N/A
- Revenue
- ISTR $88,885,000.00
- CRVS N/A
- Revenue This Year
- ISTR $2.04
- CRVS N/A
- Revenue Next Year
- ISTR $9.79
- CRVS N/A
- P/E Ratio
- ISTR $10.12
- CRVS N/A
- Revenue Growth
- ISTR 6.35
- CRVS N/A
- 52 Week Low
- ISTR $15.39
- CRVS $1.78
- 52 Week High
- ISTR $24.81
- CRVS $10.00
- Technical
- Relative Strength Index (RSI)
- ISTR 70.31
- CRVS 53.94
- Support Level
- ISTR $21.97
- CRVS $3.79
- Resistance Level
- ISTR $22.46
- CRVS $4.31
- Average True Range (ATR)
- ISTR 0.68
- CRVS 0.29
- MACD
- ISTR 0.32
- CRVS 0.00
- Stochastic Oscillator
- ISTR 90.89
- CRVS 72.64
About ISTR Investar Holding Corporation
Investar Holding Corp is a U.S.-based financial holding company. Through its subsidiaries, it offers a variety of commercial and retail lending products throughout its market areas, including business loans to small to medium-sized businesses, as well as loans to individuals. It has business operations spread across the United States and serves its customers through several service branches. The bank also offers cashiers' checks, direct deposit of payroll and Social Security checks, night depository, bank-by-mail, automated teller machines with deposit automation, and debit cards.
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).